within Pharmacolibrary.Drugs.ATC.S;

model S01EB10
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01EB10</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Paraoxon is an organophosphate compound, known primarily as the active and highly toxic metabolite of parathion, once used as a pesticide. It is a potent acetylcholinesterase inhibitor. Paraoxon is not approved for therapeutic use in humans and is considered a hazardous chemical due to its toxicity.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models specifically for paraoxon in humans are available. The following values are rough estimates based on animal models and analogy to similar organophosphate compounds.</p><h4>References</h4><ol><li><p>Hurh, E, et al., &amp; Lee, MG (2000). Effects of physostigmine on the pharmacokinetics of intravenous parathion in rats. <i>Biopharmaceutics &amp; drug disposition</i> 21(8) 331–338. DOI:<a href=&quot;https://doi.org/10.1002/bdd.243&quot;>10.1002/bdd.243</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11514953/&quot;>https://pubmed.ncbi.nlm.nih.gov/11514953</a></p></li><li><p>Hurh, E, et al., &amp; Lee, MG (2000). Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats. <i>Research communications in molecular pathology and pharmacology</i> 108(3-4) 261–273. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11913717/&quot;>https://pubmed.ncbi.nlm.nih.gov/11913717</a></p></li><li><p>Eyer, F, et al., &amp; Eyer, P (2003). Human parathion poisoning. A toxicokinetic analysis. <i>Toxicological reviews</i> 22(3) 143–163. DOI:<a href=&quot;https://doi.org/10.2165/00139709-200322030-00003&quot;>10.2165/00139709-200322030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15181664/&quot;>https://pubmed.ncbi.nlm.nih.gov/15181664</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01EB10;
